Telco/Internet specialist

Kirk Boodry

Redex Research

Thematic (Sector/Industry)

Softbank has tested 44,000 people for Covid-19 antibodies with an infection rate of 0.44% including 1.8% for medical workers and 0.23% for its own employees.  A government spokesman said these results largely match what the Health Ministry has seen implying the number of Covid-19 infections in Japan is close to 291,000. That is higher than the 17,156 confirmed cases reported through diagnostic testing (looks for active cases) but either number confirms that Japan has managed to mitigate the impacts of Covid-19 so far. Japan has been an enigma in global comparisons as Covid-19 rates stayed low despite a lack of aggressive testing, contract tracing and lock-down measures used in Korea, Taiwan and Hong Kong.  It appears that social distancing and use of PPE have helped and we look at some of the measures below.

Softbank has tested 44,000 people for Covid-19 antibodies with an infection rate of 0.44% including 1.8% for medical workers and 0.23% for its own employees.  A government spokesman said these results largely match what the Health Ministry has seen implying the number of Covid-19 infections in Japan is close to 291,000. That is higher than the 17,156 confirmed cases reported through diagnostic testing (looks for active cases) but either number confirms that Japan has managed to mitigate the impacts of Covid-19 so far. Japan has been an enigma in global comparisons as Covid-19 rates stayed low despite a lack of aggressive testing, contract tracing and lock-down measures used in Korea, Taiwan and Hong Kong.  It appears that social distancing and use of PPE have helped and we look at some of the measures below.

Softbank Covid-19 Testing Highlights Japan's Resistance to the Pandemic

Equity Bottom-Up

Softbank-backed insurtech platform Lemonade has filed a preliminary prospectus to list on NYSE. The company reportedly considered an IPO last year but Uber share price erosion and the failed WeWork listing made that unattractive for the loss-making company. The financials are modestly better now although the major change may be a recovery in equity markets that makes testing the waters palatable. This is not a major listing for Vision Fund as the estimated SVF investment of $400mn puts it mid-table in size (#33 on our list) but a successful listing would mark the first IPO for the fund since last year, signaling a path to liquidity for private investments that have caused so much concern in 2020. There are risks as Lemonade boasts the same combination of a high valuation and material operating losses that drove choppy trading for VF candidates but upside for those same companies now bodes well (VF’s public portfolio is +28% QTD). The main driver for Softbank’s share price continues to be market reactions to asset sale and debt reduction plans whilst ongoing share buybacks provide support.

Softbank-backed insurtech platform Lemonade has filed a preliminary prospectus to list on NYSE. The company reportedly considered an IPO last year but Uber share price erosion and the failed WeWork listing made that unattractive for the loss-making company. The financials are modestly better now although the major change may be a recovery in equity markets that makes testing the waters palatable. This is not a major listing for Vision Fund as the estimated SVF investment of $400mn puts it mid-table in size (#33 on our list) but a successful listing would mark the first IPO for the fund since last year, signaling a path to liquidity for private investments that have caused so much concern in 2020. There are risks as Lemonade boasts the same combination of a high valuation and material operating losses that drove choppy trading for VF candidates but upside for those same companies now bodes well (VF’s public portfolio is +28% QTD). The main driver for Softbank’s share price continues to be market reactions to asset sale and debt reduction plans whilst ongoing share buybacks provide support.

Softbank Group: When Your Private Portfolio Gives You Lemons, Offer Lemonade

The underlying value of Softbank Group is back over ¥10,000/share, the same level as mid-February just before the initial concerns about Covid-19 slammed the markets.  The corresponding share price has slightly lagged as concerns over private valuations at Vision Fund have been weighted more heavily than the positive benefits of buying backs shares, at least so far, but shares are up 94% off the 19 March low.  Softbank shares now trade at a 48% discount to fair value up compared to the all-time low of 68% and largely in-line with the levels last year after the WeWork IPO debacle. There is room for Softbank shares to move slightly higher should recent stock market gains hold but we think the discount is approaching appropriate levels.

The underlying value of Softbank Group is back over ¥10,000/share, the same level as mid-February just before the initial concerns about Covid-19 slammed the markets.  The corresponding share price has slightly lagged as concerns over private valuations at Vision Fund have been weighted more heavily than the positive benefits of buying backs shares, at least so far, but shares are up 94% off the 19 March low.  Softbank shares now trade at a 48% discount to fair value up compared to the all-time low of 68% and largely in-line with the levels last year after the WeWork IPO debacle. There is room for Softbank shares to move slightly higher should recent stock market gains hold but we think the discount is approaching appropriate levels. 

Softbank Group: Covid-19 Round Trip for the Share Price

Senior Credit Analyst, Lucror Analytics

Leonard Law, CFA

Senior Credit Analyst

High Yield Experts

Lucror Analytics

Lucror Analytics is a leading credit and ESG research specialist and a provider of technology solutions for differentiated fixed income strategies. Our roots are in bottom-up fundamental credit analysis with a specialization in high yield corporate credits from Europe, Asia and Latin America. We are one of few research specialists integrating ESG considerations with fundamental credit research through a dedicated ESG platform. Our ESG assessment covers five key criteria: Disclosure, E,S, & G Pillars, Controversies, ESG Impact on Credit and ESG Momentum.

Recognizing the importance and value-add of Factor Investing in fixed income, Lucror developed the Smart Quant Navigator (SQN), an intuitive platform that helps clients devise and implement factor-based strategies ranging from pure quant to active fundamental, with integrated ESG.

Our company has been at the forefront of developments in the fixed income markets, identifying opportunities and consistently delivering new products and value-adding solutions to clients. Lucror has close relationships with the largest and most reputable asset managers, family offices, hedge funds, investment and wealth managers globally.

Credit

From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting tensions between China and the US. In addition, China held its annual Two Sessions during the month after a delay due to COVID-19. In this report, we focus on the Government Working Report delivered at the meetings, looking for guidance on the trajectory of policy easing and the stimulus meant to drive a post-pandemic recovery. The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks and discussing specific areas of interest in the “In-Focus” section. The Asia Monthly is intended to broaden investors' understanding of the Asian USD high-yield market.

  From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting tensions between China and the US. In addition, China held its annual Two Sessions during the month after a delay due to COVID-19. In this report, we focus on the Government Working Report delivered at the meetings, looking for guidance on the trajectory of policy easing and the stimulus meant to drive a post-pandemic recovery.   The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks and discussing specific areas of interest in the “In-Focus” section. The Asia Monthly is intended to broaden investors' understanding of the Asian USD high-yield market. 

Asia HY Monthly - Takeaways From China's Two Sessions (2020) - Lucror Analytics

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

Last Week in Event SPACE: SingTel, Hang Lung, Vedanta, Sing Air, Leyou

Japan

SoftBank Group Corp. provides telecommunication services. The Company also operates ADSL (Asymmetric Digital Subscriber Line) and fiber optic high-speed Internet connection, e-Commerce businesses, and Internet based advertising and auction businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Softbank Group (9984 JP)

Softbank Covid-19 Testing Highlights Japan's Resistance to the Pandemic

Softbank has tested 44,000 people for Covid-19 antibodies with an infection rate of 0.44% including 1.8% for medical workers and 0.23% for its own...

Kirk Boodry

Softbank Group: When Your Private Portfolio Gives You Lemons, Offer Lemonade

Softbank-backed insurtech platform Lemonade has filed a preliminary prospectus to list on NYSE. The company reportedly considered an IPO last year...

Kirk Boodry

Asia HY Monthly - Takeaways From China's Two Sessions (2020) - Lucror Analytics

From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting...

Lucror Analytics

Last Week in Event SPACE: SingTel, Hang Lung, Vedanta, Sing Air, Leyou

Last Week in Event SPACE ... Singtel (ST SP)'s implied stub, stripping out all its listed holdings, has never been cheaper. Hang Lung (10...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Softbank Covid-19 Testing Highlights Japan's Resistance to the Pandemic

Softbank has tested 44,000 people for Covid-19 antibodies with an infection rate of 0.44% including 1.8% for medical workers and 0.23% for its own...

Kirk Boodry

Softbank Group: When Your Private Portfolio Gives You Lemons, Offer Lemonade

Softbank-backed insurtech platform Lemonade has filed a preliminary prospectus to list on NYSE. The company reportedly considered an IPO last year...

Kirk Boodry

Softbank Group: Covid-19 Round Trip for the Share Price

The underlying value of Softbank Group is back over ¥10,000/share, the same level as mid-February just before the initial concerns about Covid-19...

Kirk Boodry

Asia HY Monthly - Takeaways From China's Two Sessions (2020) - Lucror Analytics

From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting...

Lucror Analytics

Last Week in Event SPACE: SingTel, Hang Lung, Vedanta, Sing Air, Leyou

Last Week in Event SPACE ... Singtel (ST SP)'s implied stub, stripping out all its listed holdings, has never been cheaper. Hang Lung (10...

David Blennerhassett